StockData

Hyperfine vs QT Imaging

HYPR and QTI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HYPR and QTI compare

Hyperfine is the larger company, worth 2.4 times as much as QT Imaging ($66.7M against $27.5M).

QT Imaging grew revenue faster over the last twelve months (157% versus 80.0% for Hyperfine).

QT Imaging keeps more of each dollar of sales as profit, with a net margin of −54.6% compared with −156% at Hyperfine.

Hyperfine scores higher on the StockData Score (7 against 2 for QT Imaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHYPRQTI
Size and price
Market cap$66.7M$27.5M
Share price$0.629$1.88
Change, 1 year−42.8%−69.5%
Change, 5 years−93.7%−98.7%
Beta (5Y)1.030.05
Employees10232
StockData Score
Total score7 (better)2
Valuation score2 (better)0
Growth score3 (better)1
Performance score1 (better)0
Health score11
Dividend score00
Valuation
P/S3.5×0.9× (better)
P/B2.1× (better)10.4×
FCF yield−41.8% (better)−51.3%
Fair value$0.774–
Margin of safety18.7%–
Growth
Revenue growth (TTM)80.0%157% (better)
Revenue growth, 5Y average115%–
Profitability
Gross margin52.6% (better)40.2%
Operating margin−168%−24.9% (better)
Net margin−156%−54.6% (better)
FCF margin−146%−47.7% (better)
Return on equity−102%–
Return on invested capital−403%–
Financial health
Debt / equity0.42 (better)1.47
Current ratio5.10 (better)2.78
Altman Z-score−7.63−1.63 (better)
Piotroski F-score44
Dividends and buybacks
Buyback yield–−94.3%
Shareholder yield0.00% (better)−94.3%
Ownership
Held by institutions20.6%22.3%
Held by insiders18.1%91.5%
Insider net buying, 12 months−$91.9K$155K (better)
Short interest, % of float4.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.